Skip to main content
SpringerLink
Log in

Caring for Women with Inflammatory Bowel Disease

  • Chapter
  • First Online:
Book cover Inflammatory Bowel Disease

Part of the book series: Clinical Gastroenterology ((CG))

  • 1752 Accesses

Abstract

The menstrual cycle can affect IBD symptoms. Women with IBD are more likely to develop abnormal cervical cytology. Fertility is not affected in UC, but can be in active CD. There is no increase in adverse pregnancy outcomes in quiescent IBD. Active disease at conception increases the risk for adverse outcomes during pregnancy. The majority of medications for IBD are safe in pregnancy and breastfeeding – active disease is more deleterious than active therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kappelman MD, Rifas-Shiman SL, Klkeinman K, Ollendorf D, Bousvaros A, Grand RJ, et al. The prevelance and geographic distribution of Crohn’s disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007;5:1424–9.

    Article  PubMed  Google Scholar 

  2. Silverstein MD, Lashner BA, Hanauer SB, Evans AA, Kirsner JB. Cigarette smoking in Crohn’s disease. Am J Gastroenterol. 1989;84:31–3.

    PubMed  CAS  Google Scholar 

  3. Maunder R, Toner B, de Rooy E, Moskovitz D. Influence of sex and disease on illness-related concerns in inflammatory bowel disease. Can J Gastroenterol. 1999;13(9):728–32.

    PubMed  CAS  Google Scholar 

  4. Trachter AB, Rogers AI, Leiblum SR. Inflammatory bowel disease in women: impact on relationship and sexual health. Inflamm Bowel Dis. 2002;8(6):413–21.

    Article  PubMed  Google Scholar 

  5. Counihan TC, Roberts PL, Schoetz Jr DJ, Coller JA, Murray JJ, Veidenheimer MC. Fertility and sexual and gynecologic function after ileal pouch-anal anastomosis. Dis Colon Rectum. 1994;37:1126–9.

    Article  PubMed  CAS  Google Scholar 

  6. Kane SV, Sable K, Hanauer SB. The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: a prevalence study. Am J Gastro. 1998;93:1867–72.

    Article  CAS  Google Scholar 

  7. Erkan P, Ulku D, Canan A, Selcuk D, Bilge T, Ayse U, et al. Pattern of gastrointestinal and psychosomatic symptoms across the menstrual cycle in women with inflammatory bowel disease. Turk J Gastroenterol. 2003;14(4):250–6.

    Google Scholar 

  8. Lichtarowicz A, Norman C, Calcraft B, Morris JS, Rhodes J, Mayberry J. A study of the menopause, smoking, and contraception in women with Crohn’s disease. Q J Med. 1989;72:623–31.

    PubMed  CAS  Google Scholar 

  9. Kane S, Khatibi B, Reddy D. Higher incidence of abnormal pap smears in women with inflammatory bowel disease. Am J Gastroenterol. 2007;103(3):631–6.

    Article  PubMed  Google Scholar 

  10. Bhatia J, Bratcher J, Korelitz B, Vakher K, Mannor S, Shevchuk M, et al. Abnormalities of uterine cervix in women with inflammatory bowel disease. World J Gastroenterol. 2006;12(38):6167–71.

    PubMed  Google Scholar 

  11. Willoughby CP, Truelove SC. Ulcerative colitis and pregnancy. Gut. 1980;21:469–74.

    Article  PubMed  CAS  Google Scholar 

  12. Mayberry JF, Weterman IT. European survey of fertility and pregnancy in women with Crohn’s disease: a case control study by European collaborative group. Gut. 1986;27:821–5.

    Article  PubMed  CAS  Google Scholar 

  13. Fonager K, Sorensen HT, Olsen J, Danlevup JF, Rasmussen SN. Pregnancy outcome for women with Crohn’s disease: a follow-up study based on linkage between national registries. Am J Gastroenterol. 1998;93:2426–30.

    Article  PubMed  CAS  Google Scholar 

  14. Alstead E. Fertility and pregnancy in inflammatory bowel disease. World J Gastroenterol. 2001;7(4):455–9.

    PubMed  CAS  Google Scholar 

  15. Waljee A, Waljee J, Morris A, Higgin PD. Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis. Gut. 2006;55:1575–80.

    Article  PubMed  CAS  Google Scholar 

  16. Mortier PE, Gambiez L, Karoui M, Cortot A, Paris JC, Quandalle P, et al. Colectomy with ileorectal anastomosis presevers female fertility in ulcerative colitis. Gastroenterol Clin Biol. 2006;30:594–7.

    Article  PubMed  Google Scholar 

  17. O’Morian C, Smethurst P, Dore CJ, Levi AJ. Reversible male infertility due to sulphasalazine: studies in man and rat. Gut. 1984;25:1078–84.

    Article  Google Scholar 

  18. Burnell D, Mayberry J, Calcraft BJ, Morris JS, Rhodes J. Male fertility in Crohn’s disease. Postgrad Med J. 1986;62:269–72.

    Article  PubMed  CAS  Google Scholar 

  19. Miller JP. Inflammatory bowel disease in pregnancy: a review. J R Soc Med. 1986;79:221–5.

    PubMed  CAS  Google Scholar 

  20. Orholm M, Fonager K, Sorensen HT. Risk of ulcerative colitis and Crohn’s disease among offspring of patients with chronic inflammatory bowel disease. Am J Gastroenterol. 1999;94:3236–8.

    Article  PubMed  CAS  Google Scholar 

  21. Yang H, McElree C, Roth MP, Shanahan F, Targan SR, Rotter JI. Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut. 1993;34:517–24.

    Article  PubMed  CAS  Google Scholar 

  22. Hanker JP. Gastrointestinal disease and oral contraception. Am J Obstet Gynecol. 1990;163:2204–7.

    Article  PubMed  CAS  Google Scholar 

  23. Boyko EJ, Theis MK, Vaughan TL, Nicol-Blades B. Increased risk of inflammatory bowel disease associated with oral contraceptive use. Am J Epidemiol. 1994;140:268–78.

    PubMed  CAS  Google Scholar 

  24. Lesko SM, Kaufman DW, Rosenberg L, Helmrich SP, Miller DR, Stolley PD, et al. Evidence for an increased risk of Crohn’s disease in oral contraceptive users. Gastroenterology. 1985;89:1046–9.

    PubMed  CAS  Google Scholar 

  25. Sandler RS, Wurzelmann JI, Lyles CM. Oral contraceptive use and the risk of inflammatory bowel disease. Epidemiology. 1992;3:374–8.

    Article  PubMed  CAS  Google Scholar 

  26. Lashner BA, Kane SV, Hanauer SB. Lack of association between oral contraceptive use and Crohn’s disease: a community-based matched case-control study. Gastroenterology. 1989;97(6):1442–7.

    PubMed  CAS  Google Scholar 

  27. Lashner BA, Kane SV, Hanauer SB. Lack of association between oral contraceptive use and ulcerative colitis. Gastroenterology. 1990;99(4):1032–6.

    PubMed  CAS  Google Scholar 

  28. Godet PG, May GR, Sutherland LR. Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease. Gut. 1995;37:668–73.

    Article  PubMed  CAS  Google Scholar 

  29. Cosnes J, Carbonnel F, Carrat F, Beaugerie L, Gendre JP. Oral contraceptive use and the clinical course of Crohn’s disease: a prospective cohort study [see comments]. Gut. 1999;45:218–22.

    Article  PubMed  CAS  Google Scholar 

  30. Timmer A, Sutherland LR, Martin F. Oral contraceptive use and smoking are risk factors for relapse in Crohn’s disease. The Canadian mesalamine for remission of Crohn’s disease study group. Gastroenterology. 1998;114:1143–50.

    Article  PubMed  CAS  Google Scholar 

  31. Cottone M, Camma C, Orlando A. Oral Contraceptive and Recurrence in Crohn’s Disease. Gastroenterol. 1999;116:A693.

    Article  Google Scholar 

  32. Moser MA, Okun NB, Mayes DC, Bailey RJ. Crohn’s disease, pregnancy, and birth weight. Am J Gastroenterol. 2000;95:1021–6.

    Article  PubMed  CAS  Google Scholar 

  33. Norgard B, Hundborg HH, Jacobsen BA, Nielsen GL, Fonager K. Disease activity in pregnant women with Crohn’s disease and birth outcomes: a regional Danish cohort study. Am J Gastroenterol. 2007;102:1947–54.

    Article  PubMed  Google Scholar 

  34. Porter RJ, Stirrat GM. The effects of inflammatory bowel disease on pregnancy: a case- controlled retrospective analysis. Br J Obstet Gynaecol. 1986;93:1124–31.

    Article  PubMed  CAS  Google Scholar 

  35. Ilnyckyj A, Blanchard JF, Rawsthorne P, Bernstein CN. Perianal Crohn’s disease and pregnancy: role of the mode of delivery. Am J Gastroenterol. 1999;94:3274–8.

    Article  Google Scholar 

  36. Cornish J, Tan E, Teoh T, Teare TG, Rai R, Clark SK, et al. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut. 2007;56:830–7.

    Article  PubMed  CAS  Google Scholar 

  37. Cappell MS, Colon VJ, Sidhom OA. A study at 10 medical centers of the safety and efficacy of 48 flexible sigmoidoscopies and 8 colonoscopies during pregnancy with follow-up of fetal outcome and with comparison to control groups. Dig Dis Sci. 1996;41:2353–61.

    Article  PubMed  CAS  Google Scholar 

  38. Nwokolo C, Tan WC, Andrews HA, Allan RN. Surgical resections in parous patients with distal ileal and colonic Crohn’s disease. Gut. 1994;35:220–3.

    Article  PubMed  CAS  Google Scholar 

  39. Riis L, Vind I, Politi P, Wolters F, Vermeire S, Tsianos E, et al. Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease. Am J of Gastroenterol. 2006;101:1539–45.

    Article  Google Scholar 

  40. Sachar D. Exposure to mesalamine during pregnancy increased preterm deliveries (but not birth defects) and decreased birth weight. Gut. 1998;43:316.

    Article  PubMed  CAS  Google Scholar 

  41. Diav-Citrin O, Park YH, Veerasuntharam G, Polacheck H, Bologa M, Pastuszak A, et al. The safety of mesalamine in human pregnancy: a prospective controlled cohort study. Gastroenterology. 1998;114:23–8.

    Article  PubMed  CAS  Google Scholar 

  42. Marteau P, Tennenbaum R, Elefant E, Lemann M, Cosnes J. Foetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine microgranules. Aliment Pharmacol Ther. 1998;12:1101–8.

    Article  PubMed  CAS  Google Scholar 

  43. McKay DB, Josephson AM. Pregnancy in recipients of solid organs–effects on mother and child. N Engl J Med. 2006;354(12):1281–93.

    Article  PubMed  CAS  Google Scholar 

  44. Alstead EM, Ritchie JK, Lennard-Jones JE, Farthing MJ, Clark ML. Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology. 1990;99:443–6.

    PubMed  CAS  Google Scholar 

  45. Francella A, Dayan A, Bodian C, Rubin P, Chapman M, Present DH. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology. 2003;124(1):9–17.

    Article  PubMed  CAS  Google Scholar 

  46. De Boer NK, Jarbandhan SV, Peer de Graff MS, Mulder CJ, van Elburg RM, von Bodegraven AA. Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites. Am J Gastroenterol. 2006;101:1390–92.

    Article  PubMed  Google Scholar 

  47. Norgard B, Pedersen L, Christensen LA, Sorensen HT. Therapeutic drug use in women with Crohn’s disease and birth outcomes: a Danish nationwide cohort study. Am J Gastroenterol. 2007;102:1406–13.

    Article  PubMed  Google Scholar 

  48. Mahadevan U, Kane S, Sandborn WJ, Cohen RD, Hanson K, Terdiman JP, et al. Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn’s disease. Aliment Pharmacol Ther. 2005;21:733–8.

    Article  PubMed  CAS  Google Scholar 

  49. Vasiliauskas EA, Chruch JA, Silverman N, Barry M, Targan SR, Dubinsky MC. Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol. 2006;4:1255–8.

    Article  PubMed  Google Scholar 

  50. Mishkin D, van Deinse W, Becker J, Farraye FA. Successful use of adalimumab for Crohn’s disease in pregnancy. Inflamm Bowel Dis. 2006;12(8):827–8.

    Article  PubMed  Google Scholar 

  51. Vesga L, Terdiman JP, Mahadevan U. Adalimumab use in pregnancy. Gut. 2005;54(6):890.

    Article  PubMed  CAS  Google Scholar 

  52. Rosa FW, Baum C, Shaw M. Pregnancy outcomes after first-trimester vaginitis drug therapy. Obstet Gynecol. 1987;69:751–5.

    PubMed  CAS  Google Scholar 

  53. Juhasz ES, Fozard B, Dozois RR, Ilstrup DM, Nelson H. Ileal pouch-anal anastomosis ­function following childbirth. An extended evaluation Dis Colon Rectum. 1995;38:159–65.

    Article  CAS  Google Scholar 

  54. Cornish J, Tan E, Teare J, Teoh T, Rai R, Darzi A, et al. The effect of restorative proctocolectomy on sexual function, urinary function, fertility, pregnancy, and delivery: a systematic review. Dis Colon Rectum. 2007;50:1128–38.

    Article  PubMed  Google Scholar 

  55. Lepisto A, Sarna S, Tiitinen A, Jarvinen HJ. Female fertility and childbirth after ileal pouch-anal anastomosis for ulcerative colitis. Br J Surg. 2007;94:478–82.

    Article  PubMed  CAS  Google Scholar 

  56. Tiainen J, Matikainen M, Hiltunen KM. Ileal J-pouch–anal anastomosis, sexual dysfunction, and fertility. Scand J Gastroenterol. 1999;34:185–8.

    Article  PubMed  CAS  Google Scholar 

  57. Damgaard B, Wettergren A, Kirkegaard P. Social and sexual function following ileal pouch-anal anastomosis. Dis Colon Rectum. 1995;38:286–9.

    Article  PubMed  CAS  Google Scholar 

  58. Bambrick M, Fazio VW, Hull TL, Pucel G. Sexual function following restorative proctocolectomy in women. Dis Colon Rectum. 1996;39:610–4.

    Article  PubMed  CAS  Google Scholar 

  59. Metcalf AM, Dozois RR, Kelly KA. Sexual function in women after proctocolectomy. Ann Surg. 1986;204(6):624–8.

    Article  PubMed  CAS  Google Scholar 

  60. Kane S, Reddy D. Hormone replacement therapy after menopause is protective of disease activity in women with inflammatory bowel disease. Am J Gastroenterol. 2008;103(5):1193–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, 55905, USA

    Sunanda Kane

Authors
  1. Sunanda Kane
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rebecca Kowalczyk
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sunanda Kane .

Editor information

Editors and Affiliations

  1. MC 4076, Sect. Of GE, Hepatol. & Nutr., Department of Medicine, University of Chicago Medical Center, S. Maryland Ave. 5841, Chicago, 60637, Illinois, USA

    Russell D. Cohen

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Kane, S., Kowalczyk, R. (2011). Caring for Women with Inflammatory Bowel Disease. In: Cohen, R. (eds) Inflammatory Bowel Disease. Clinical Gastroenterology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-433-3_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-433-3_13

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60327-432-6

  • Online ISBN: 978-1-60327-433-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation